These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18714163)

  • 1. Prolongation of survival and improvement in performance status following palliative chemotherapy in gastrointestinal cancer patients with a poor performance status.
    Shitara K; Munakata M; Kasai M; Muto O; Sakata Y
    Oncology; 2008; 74(3-4):135-42. PubMed ID: 18714163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
    Shuch B; La Rochelle JC; Wu J; Klatte T; Riggs SB; Kabbinavar F; Belldegrun AS; Pantuck AJ
    Cancer; 2008 Sep; 113(6):1324-31. PubMed ID: 18661529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
    Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.
    Kim YH; Goto K; Yoh K; Niho S; Ohmatsu H; Kubota K; Saijo N; Nishiwaki Y
    Cancer; 2008 Nov; 113(9):2518-23. PubMed ID: 18780323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy.
    Persson C; Glimelius B
    Anticancer Res; 2002; 22(6B):3661-8. PubMed ID: 12552973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.
    Chamberlain MC; Johnston SK; Glantz MJ
    Arch Neurol; 2009 Jan; 66(1):74-8. PubMed ID: 19139302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
    von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
    Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
    Inoue A; Kobayashi K; Usui K; Maemondo M; Okinaga S; Mikami I; Ando M; Yamazaki K; Saijo Y; Gemma A; Miyazawa H; Tanaka T; Ikebuchi K; Nukiwa T; Morita S; Hagiwara K;
    J Clin Oncol; 2009 Mar; 27(9):1394-400. PubMed ID: 19224850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Palliative chemotherapy in metastatic and locally advanced gastrointestinal tumor].
    Dippold W
    Zentralbl Chir; 1998; 123(6):722-4. PubMed ID: 9703647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
    Pectasides D; Papaxoinis G; Fountzilas G; Aravantinos G; Bamias A; Pavlidis N; Kalofonos HP; Timotheadou E; Samantas E; Briasoulis E; Skarlos DV; Economopoulos T; Dimopoulos MA;
    Anticancer Res; 2009 Feb; 29(2):745-51. PubMed ID: 19331231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction.
    Wang Z; Chen K; Gong J; Zheng Y; Wang T
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
    Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4CD25+ regulatory T cells in patients with advanced gastrointestinal cancer treated with chemotherapy.
    Xu H; Mao Y; Dai Y; Wang Q; Zhang X
    Onkologie; 2009 May; 32(5):246-52. PubMed ID: 19420970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome.
    Hong SH; Koh YH; Rho SY; Byun JH; Oh ST; Im KW; Kim EK; Chang SK
    Jpn J Clin Oncol; 2009 Jan; 39(1):54-61. PubMed ID: 18997182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of pleural fluid data in patients with malignant effusion.
    Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
    Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
    Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
    Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.